Premium
Burden of fungal infections in Qatar
Author(s) -
TajAldeen Saad J.,
Chandra Prem,
Denning David W.
Publication year - 2015
Publication title -
mycoses
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.13
H-Index - 69
eISSN - 1439-0507
pISSN - 0933-7407
DOI - 10.1111/myc.12386
Subject(s) - aspergillosis , mucormycosis , medicine , allergic bronchopulmonary aspergillosis , case fatality rate , population , asthma , pneumonia , cryptococcosis , immunology , environmental health , surgery , immunoglobulin e , antibody
Summary Few estimates of fungal disease frequency have been attempted in the Middle East. We have estimated the burden of fungal infections in Qatar. The aim of the study was to compute and determine the burden of serious fungal infections, in an attempt to estimate fungal disease frequency, which has not previously been attempted in this country. Disease statistics were collected from the Microbiology laboratory database and from 2011 WHO statistics. The data are expressed per 100 000 populations. The reported cases of candidaemia rose to 288 with an estimated rate of 15.4/100 000. A real increase in the burden of candidaemia was found over that previously reported (12.9/100 000) for the years 2004–2009. Candida peritonitis was estimated in 8.02 cases/100 000 population. Recurrent (≥4 year −1 ) vaginal infections affect at least 32 782 women with a rate of 3506/100 000 inhabitants. Severe asthma with fungal sensitisation affected 1486 people, allergic bronchopulmonary aspergillosis 1126 people and chronic pulmonary aspergillosis 176 people. Rhinosinusitis, mucormycosis and Fusarium infection occurred at rates of 2.31, 1.23, 1.86 cases/100 000 respectively. The estimated rate of invasive aspergillosis was very low (0.6/100 000). Low rates of Cryptococcus meningitis and Pneumocystis pneumonia are attributable to low HIV infection rates. In conclusion, fungal infections are increasingly reported, especially candidaemia. Surveillance and guidelines are needed to optimise care and management of common fungal infections. In addition, a fungal registry system needs development for surveillance.